Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2003
09/25/2003US20030180370 Iron oxide core with overcoating shell; antitumor agents
09/25/2003US20030180318 Composition having anticancer activity
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180296 Antibodies that immunospecifically bind to trail receptors
09/25/2003US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
09/25/2003US20030180287 Polypeptide formulation
09/25/2003US20030180275 Human serpin polypeptides
09/25/2003US20030180253 Stabilized liquid polypeptide-containing pharmaceutical compositions
09/25/2003US20030180224 Photosensitisers
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479350A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/25/2003CA2479315A1 Improvements in vaccination
09/25/2003CA2479307A1 Virus like particle from papillomavirus and their use in vaccine
09/25/2003CA2479304A1 Virus-like particles of human papillomavirus
09/25/2003CA2479212A1 Central airway administration for systemic delivery of therapeutics
09/25/2003CA2478909A1 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003CA2478803A1 Methods of modulating cd200 receptors
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478760A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478534A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
09/25/2003CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque
09/25/2003CA2477832A1 Methods of treating diabetes using pde 11a inhibitors
09/25/2003CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/24/2003EP1347054A1 TAP-70, a novel marker for epithelial tumors
09/24/2003EP1347042A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1346983A2 Phthalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign prostatic hyperplasia
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1346745A1 Apparatus for treatment of tumor in the central nervous system (CNS)
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1346727A2 Method for obtaining antigenic aggregates and the use thereof in formulations
09/24/2003EP1346725A1 Pharmaceutical composition comprising PIM-activated NKT cells, and therapeutic use thereof
09/24/2003EP1346226A1 Screening method based on siah-numb interaction
09/24/2003EP1346065A2 Antisense modulation of src-2 expression
09/24/2003EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2)
09/24/2003EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol
09/24/2003EP1346058A2 Adenoviral systems and the uses thereof
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
09/24/2003EP1346053A2 Polynucleotides encoding human phosphatases
09/24/2003EP1346045A1 Human protooncogene and protein encoded therein
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346039A1 Human cervical cancer 2 protooncogene and protein encoded therein
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
09/24/2003EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/24/2003EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
09/24/2003EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
09/24/2003EP1345957A2 Inhibitors of the e2f-1/cyclin interaction for cancer therapy
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345951A1 A substance or composition for the treatment of cancer
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345944A1 Process for the isolation and purification of epothilones
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345914A1 Therapeutic compounds
09/24/2003EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345899A1 Compounds
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345617A2 Methods of modulating toll-related receptor (trr) signaling
09/24/2003EP1345616A2 Reducing cellular damage in the human body
09/24/2003EP1345606A2 Texaphyrin coordination compounds and uses thereof
09/24/2003EP1345604A1 Antitumor therapy comprising distamycin derivatives
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1345600A1 New clinical treatment
09/24/2003EP1265898B1 1,8-NAPHTHALIMIDE IMIDAZO 4,5,1- i de /i ]ACRIDONES WITH ANTI-TUMOR ACTIVITY
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1178965B1 Quinoline derivatives as inhibitors of mek enzymes
09/24/2003EP1123109B1 Contulakin-g, analogs thereof and uses therefor
09/24/2003EP1117428B1 Compositions and their use for inhibiting angiogenesis
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/24/2003EP1098656B1 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/24/2003EP1011329B1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
09/24/2003EP0986569B1 Process for preparing etoposide
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0973746B1 Substituted 3-cyano quinolines
09/24/2003EP0876362B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
09/24/2003CN1444654A Novel therapeutic molecular variants and uses thereof
09/24/2003CN1444648A Method of amplifying natural killer T cells
09/24/2003CN1444600A Use of ADNF polypeptides for enhancing learning and memory
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
1 ... 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 ... 2211